Answers are grounded in this paper and cite their sources.
Systematic review evaluates long-term survival of shoulder implants over 13 years, indicating good outcomes.
Aims It is known that survival of primary total shoulder arthroplasty at 10 years is excellent; however, evidence beyond this time-point is limited. We aimed to evaluate the long-term survival of anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA) implants, at ≥13 years follow-up, using case series and international joint registry data. Methods CENTRAL, Embase, and MEDLINE databases were searched for studies reporting TSA survival data at ≥13 years follow-up. National joint registries were contacted for implant data. Pooled survival at 13, 15, and 20 years was calculated for case series and registry data using a random-effects model. Results Data from four national joint registries and seven studies were analysed. Pooled aTSA registry data showed survival of 91.50% (89.36–93.64) at 13-years and 90.82% (88.25–93.38) at 15-years. Pooled rTSA registry data showed survival of 93.19% (91.78–94.60) at 13-years and 90.74% (85.73–95.74) at 15-years. Data from case series gave pooled aTSA survival estimates of 88.69% (76.97–100.42), 90.23% (85.87–94.58) and 82.08% (70.30–93.88) at 13, 15 and 20 years, respectively. Conclusion Our analysis suggests approximately 90% of shoulder replacements last up to 15 years without revision. Variation between individual implants highlights the need for granular implant-level data to guide patient and clinician decision making.
No takes yet. Share an insight, caveat, or question.
Bhatti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: